Report ID : 10352288 |
Published Date : 21 Mar 2025 |
Report Format : PDF,PPT |
Delivery Timeline :48-72 Business Hours
Global External Pacemaker Market Highlights Over 2018 - 2028
The global external pacemaker market is estimated to garner a revenue of USD 1809.94 Million by the end of 2028 by growing at a CAGR of 7.22% over the forecast period, i.e., 2021 – 2028. Moreover, in the year 2018, the market registered a revenue of USD 899.15 Million. The growth of the market can be attributed to growing research and development activities in the field of medical science which is resulting in the development of advanced life-saving medical equipment. Earlier, the pacemakers were large in size and also were bulky as compared to the pacemakers that are available in the market today. Over the years, with the advancements in technology, medical equipment organizations have introduced sophisticated pacemakers that are easy to manage and also have longer lifespan. The pacemakers of modern era also require less time for setting up the device and the pacing is done with the help of a computer software. Besides this, the growing prevalence of cardiovascular diseases worldwide is expected to possess a significant opportunity to boost the market growth in the coming years. According to the statistics by the World Health Organization (WHO), in the year 2019, around 17.9 Million people died from cardiovascular diseases (CVDs). Moreover, in the same year, out of the 17 Million premature deaths due to noncommunicable diseases, 38% of the deaths were caused by cardiovascular diseases. Moreover, increasing healthcare expenditure worldwide is also expected to accelerate the market growth remarkably during the forecast period. According to the statistics by the World Bank, the current health expenditure around the globe as a share of GDP increased from 9.431% in the year 2012 to 9.856% in the year 2018.
CLICK TO DOWNLOAD SAMPLE REPORT
Global External Pacemaker Market Regional Synopsis
Regionally, the global external pacemaker market is segmented into six major regions including North America, Europe (excluding Western Europe), Western Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is anticipated to garner the largest revenue of USD 708.78 Million by the end of 2028, up from a revenue of USD 346.22 Million in the year 2018. The growth of the market in the region can primarily be attributed to the growing awareness for the treatment of cardiovascular diseases, backed by the surge in prevalence of the disease, along with the presence of a strong healthcare network in the region, especially in the United States. According to the statistics by the Centers for Disease Control and Prevention (CDC), in the United States, around 659000 people die from heart disease every year. This represents 1 in every 4 deaths in the nation. Moreover, between 2016 and 2017, around USD 363 Billion was the cost of heart disease in the nation each year.
On the other hand, the market in Western Europe is anticipated to garner the second-largest revenue of USD 472.50 Million by the end of 2028, up from a revenue of USD 239.74 Million in the year 2018. The market in the region is further segmented by country into United Kingdom, Germany, France, Italy, Spain, Denmark, Portugal, and the Rest of Western Europe. Out of these, the market in Germany is anticipated to garner the largest revenue of USD 44.47 Million by the end of 2028, up from a revenue of USD 23.47 Million in the year 2018.
Growth Drivers and Challenges Impacting the Growth of the Global External Pacemaker Market
Growth Drivers
-
Growing Prevalence of Cardiovascular Diseases
-
Increasing Healthcare Expenditure
-
Growing Research & Development Activities
Challenges
-
High Cost of the Product
-
Numerous Instances of Failure in the Functioning of the Product
Global External Pacemaker Market Segmentation Synopsis
The global external pacemaker market is segmented by product into pulse generator device, and leads, out of which, the leads segment is projected to grow with the highest CAGR of 8.02% during the forecast period. By device, the market is segmented into single chamber, dual chamber, and triple chamber. Out of these, the dual chamber segment is anticipated to garner the largest revenue of USD 1099.92 Million by the end of 2028, up from a revenue of USD 529.84 Million in the year 2018. By distribution channel, the market is segmented into online and offline. Out of these, the online segment is anticipated to grow with the highest CAGR of 7.86% during the forecast period. By end-user, the market is segmented into hospitals, ambulatory surgical centers, and others. Out of these, the ambulatory surgical centers segment is anticipated to generate the largest revenue of USD 1276.54 Million by the end of 2028, up from a revenue of USD 639.74 Million in the year 2020.
Key Companies Dominating the Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global external pacemaker market that are included in our report are Biotronik SE & Co. KG, Medtronic PLC, Osypka Medical GmbH, Braile Biomedica, Boston Scientific Corporation, OSCOR Inc., Galix Biomedical Instrumentation, Shree Pacetronix Ltd., and others.
Latest Developments in the Global External Pacemaker Market:
-
January 21st, 2020: Medtronic PLC announced that it has received an approval from the U.S. Food and Drug Administration (FDA) for its smallest pacemaker in the world, Micra AV.
-
December 2nd, 2021: Boston Scientific Corporation announced that it has initiated the trial to evaluate the effectiveness, performance and safety of the mCRM Modular Therapy System, which includes two cardiac rhythm management (CRM) devices, namely EMBLEM MRI Subcutaneous Implantable Defibrillator (S-ICD) System and the EMPOWER Modular Pacing System (MPS), intended to work together to coordinate therapy.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
1.
Introduction
1.1.
Market Definition
1.2.Market Segmentation
1.3.Product Overview
2.
Assumptions and
Acronyms
3.
Research Methodology
4.
Executive Summary –
Global External Pacemaker Market
5.
Market Dynamics
5.1.
Drivers
5.2.
Restraints
5.3.
Trends
6.
Key Market
Opportunities
7.
Risk Analysis
7.1.
Demand Risk Analysis
7.2.
Supply Risk Analysis
8.
Impact of COVID-19 on
External Pacemaker and Overall Healthcare Industry
9.
Policy and Regulatory
Landscape
10.
Industry Growth
Outlook
11.
Technology Analysis
12.Demand and Consumption Analysis
13.Industry Value Chain Analysis
14.Global Eternal Pacemaker Market Outlook
14.1.
By Value (USD Million)
14.2.
By Volume (Units)
14.3.
By Product
14.3.1.
Pulse Generator
Device, 2018-2028F (USD million) (Units)
14.3.2.
Leads, 2018-2028F (USD
million) (Units)
14.4.
By Device
14.4.1.
Single Chamber, 2018-2018F
(USD million) (Units)
14.4.2.
Dual Chamber,
2018-2028F (USD million) (Units)
14.4.3.
Triple Chamber,
2018-2028F (USD million) (Units)
14.5.
By Distribution
Channel
14.5.1.
Offline, 2018-2028F
(USD million) (Units)
14.5.2.
Online, 2018-2028F
(USD million) (Units)
14.6.
By End User
14.6.1.
Hospitals, 2018-20280F
(USD million) (Units)
14.6.2.
Ambulatory Surgical
Centers, 2018-2028F (USD million) (Units)
14.6.3.
Others, 2018-2028F
(USD million) (Units)
14.7.
Global External
Pacemaker Market, By Region, 2018-2028F
14.7.1.
Europe (Excluding
Western Europe), 2018-2028F (USD million) (Units)
14.7.2.
Western Europe,
2018-2028F (USD million) (Units)
14.7.3.
North America,
2018-2028F (USD million) (Units)
14.7.4.
Asia Pacific,
2018-2028F (USD million) (Units)
14.7.5.
Latin America,
2018-2028FF (USD million) (Units)
14.7.6.
Middle East &
Africa, 2018-2028F (USD million) (Units)
15.
North America External
Pacemaker Market Outlook
15.1.
By Value (USD Million)
15.2.
By Volume (Units)
15.3.
By Product
15.3.1.
Pulse Generator
Device, 2018-2028F (USD million) (Units)
15.3.2.
Leads, 2018-2028F (USD
million) (Units)
15.4.
By Device
15.4.1.
Single Chamber,
2018-2018F (USD million) (Units)
15.4.2.
Dual Chamber,
2018-2028F (USD million) (Units)
15.4.3.
Triple Chamber,
2018-2028F (USD million) (Units)
15.5.
By Distribution
Channel
15.5.1.
Offline, 2018-2028F
(USD million) (Units)
15.5.2.
Online, 2018-2028F
(USD million) (Units)
15.6.
By End User
15.6.1.
Hospitals, 2018-20280F
(USD million) (Units)
15.6.2.
Ambulatory Surgical
Centers, 2018-2028F (USD million) (Units)
15.6.3.
Others, 2018-2028F
(USD million) (Units)
15.7.
By Country
15.7.1.
United States,
2019-2028F (USD Million) (Units)
15.7.2.
Canada, 2019-2028F
(USD Million) (Units)
16.Europe (Excluding Western Europe) External Pacemaker
Market Outlook
16.1.
By Value (USD Million)
16.2.
By Volume (Units)
16.3.
By Product
16.4.
By Device
16.5.
By Distribution
Channel
16.6.
By End User
17.
Western Europe External
Pacemaker Market Outlook
17.1.
By Value (USD Million)
17.2.
By Volume (Units)
17.3.
By Product
17.4.
By Device
17.5.
By Distribution Channel
17.6.
By End User
17.7.
By Country
17.7.1.
United Kingdom,
2018-2018F (USD million) (Units)
17.7.2.
Germany, 2018-2018F
(USD million) (Units)
17.7.3.
France, 2018-2018F
(USD million) (Units)
17.7.4.
Italy, 2018-2018F (USD
million) (Units)
17.7.5.
Spain, 2018-2018F (USD
million) (Units)
17.7.6.
Denmark, 2018-2018F
(USD million) (Units)
17.7.7.
Portugal, 2018-2018F
(USD million) (Units)
17.7.8.
Rest of Western Europe,
2018-2018F (USD million) (Units)
18.Asia Pacific External Pacemaker Market Outlook
18.1.
By Value (USD Million)
18.2.
By Volume (Units)
18.3.
By Product
18.4.
By Device
18.5.
By Distribution
Channel
18.6.
By End User
18.7.
By Country
18.7.1.
China, 2018-2018F (USD
million) (Units)
18.7.2.
India, 2018-2018F (USD
million) (Units)
18.7.3.
Japan, 2018-2018F (USD
million) (Units)
18.7.4.
South Korea,
2018-2018F (USD million) (Units)
18.7.5.
Australia, 2018-2018F
(USD million) (Units)
18.7.6.
Malaysia, 2018-2018F
(USD million) (Units)
18.7.7.
Rest of Asia Pacific,
2018-2018F (USD million) (Units)
19.Latin America External Pacemaker Market Outlook
19.1.
By Value (USD Million)
19.2.
By Volume (Units)
19.3.
By Product
19.4.
By Device
19.5.
By Distribution
Channel
19.6.
By End User
19.7.
By Country
19.7.1.
Brazil, 2018-2018F
(USD million) (Units)
19.7.2.
Mexico, 2018-2018F
(USD million) (Units)
19.7.3.
Rest of Latin America,
2018-2018F (USD million) (Units)
20.
Middle East &
Africa External Pacemaker Market Outlook
20.1.
By Value (USD Million)
20.2.
By Volume (Units)
20.3.
By Product
20.4.
By Device
20.5.
By Distribution
Channel
20.6.
By End User
20.7.
By Country
20.7.1.
United Arab Emirates,
2018-2018F (USD million) (Units)
20.7.2.
Saudi Arabia,
2018-2018F (USD million) (Units)
20.7.3.
Israel, 2018-2018F
(USD million) (Units)
20.7.4.
South Africa,
2018-2018F (USD million) (Units)
20.7.5.
Rest of Middle East
& Africa, 2018-2018F (USD million) (Units)
21.Product Feature Analysis
22.
Competitive
Positioning
23.
Competitive Landscape
23.1.
Medtronic PLC Market
Share
23.2.
Competitive
Benchmarking
23.3.
Company Profiles
23.3.1.
Biotronik SE & Co. KG
23.3.2.
Medtronic PLC
23.3.3.
Osypka Medical GmbH
23.3.4.
Braile Biomedica
23.3.5.
Boston Scientific Corporation
23.3.6.
OSCOR Inc.
23.3.7.
Galix Biomedical Instrumentation
23.3.8.
Shree Pacetronix Ltd.
24.
Strategic Recommendations
